Skip to main content

Table 6 Comparison between controlled and uncontrolled patients regarding their clinical parameters

From: Screening for B cell, T cell and natural killer cell defects among children with methylmalonic and propionic acidemias

Variables

Controlled

Uncontrolled

Independent t test

N = 18

N = 12

t/χ2*

p value

Age (mo.)

Mean ± SD

34.78 ± 23.50

42.67 ± 22.91

0.91

0.371

Range

10–86

6–72

Sex (n (%))

Female

11 (61.1%)

5 (41.7%)

1.094

0.296*

Male

7 (38.9%)

7 (58.3%)

Weight (p)

Mean ± SD

21.78 ± 26.20

29.17 ± 29.09

0.724

0.475

Range

3–75

3–75

Height (p)

Mean ± SD

6.28 ± 5.63

14.08 ± 23.39

1.369

0.182

Range

3–25

3–75

Age at metabolic disease onset

Mean ± SD

6.29 ± 4.65

7.00 ± 4.65

0.407

0.687

Range

0.3–19

0–12

Age of onset of infection (mo.)

Mean ± SD

5.72 ± 4.87

6.59 ± 3.83

0.518

0.608

Range

0.03–19

0.1–12

Average duration of antibiotics use at time of infection (days)

Mean ± SD

6.00 ± 0.84

5.75 ± 1.06

− 0.721

0.477

Range

4–7

4–7

Frequency of hospitalization

due to infection/year

Once

8 (44.4%)

4 (33.3%)

0.833

0.659*

Twice

6 (33.3%)

6 (50.0%)

Thrice

4 (22.2%)

2 (16.7%)

Average duration of infection (days)

Mean ± SD

6.67 ± 1.19

6.50 ± 1.31

− 0.361

0.721

Range

4–8

4–8

  1. mo. months, N number, p percentile, SD standard deviation, % percentage
  2. *Chi-square test